However, it now faces a battle for survival after the heyday when millions of individuals rushed to send it saliva samples in exchange for in-depth studies about their genetic makeup, familial ties, and lineage.
It barely missed being delisted from the stock market this week, and its share price has fallen.
Naturally, this business also has the most private information about its clients, which raises concerns about what might happen to its enormous and incredibly valuable database of unique human DNA.
23andMe was optimistic about its future when the BBC approached it, stating that company was still “committed to protecting customer data and consistently focused on maintaining the privacy of our customers.”
